NO903001L - PROCEDURE FOR MANUFACTURING PHARMACEUTICAL PREPARATIONS WITH EXTENDED RELEASE. - Google Patents

PROCEDURE FOR MANUFACTURING PHARMACEUTICAL PREPARATIONS WITH EXTENDED RELEASE.

Info

Publication number: NO903001L
Authority: NO; Norway
Prior art keywords: procedure; pharmaceutical preparations; extended release; manufacturing pharmaceutical; manufacturing
Prior art date: 1989-07-07

Application number

NO90903001A

Other languages

Norwegian (no)

Other versions

NO302928B1 (en

NO903001D0 (en

Inventor

David Bodmer

Jones Wing Fong

Thomas Kissel

Hawkins Valliant Maulding

Oskar Nagele

Jane Edna Pearson

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-07-07

Filing date

1990-07-05

Publication date

1991-01-08

1990-07-05 Application filed by Sandoz Ag filed Critical Sandoz Ag

1990-07-05 Publication of NO903001D0 publication Critical patent/NO903001D0/en

1991-01-08 Publication of NO903001L publication Critical patent/NO903001L/en

1996-01-08 Priority to NO960075A priority Critical patent/NO960075D0/en

1996-01-08 Priority to NO19960076A priority patent/NO318810B1/en

1998-05-11 Publication of NO302928B1 publication Critical patent/NO302928B1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO903001A 1989-07-07 1990-07-05 Process for the preparation of microparticles NO302928B1 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
NO960075A NO960075D0 (en)	1989-07-07	1996-01-08	Process for the preparation of a sustained-release pharmaceutical composition
NO19960076A NO318810B1 (en)	1989-07-07	1996-01-08	Process for the preparation of octreotide pamoate.

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US37702389A	1989-07-07	1989-07-07
US41134789A	1989-09-22	1989-09-22

Publications (3)

Publication Number	Publication Date
NO903001D0 NO903001D0 (en)	1990-07-05
NO903001L true NO903001L (en)	1991-01-08
NO302928B1 NO302928B1 (en)	1998-05-11

Family

ID=27007654

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO903001A NO302928B1 (en)	1989-07-07	1990-07-05	Process for the preparation of microparticles
NO19983923A NO320444B1 (en)	1989-07-07	1998-08-26	Process for the preparation of a sustained release pharmaceutical composition

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO19983923A NO320444B1 (en)	1989-07-07	1998-08-26	Process for the preparation of a sustained release pharmaceutical composition

Country Status (27)

Country	Link
JP (5)	JPH0832624B2 (en)
KR (2)	KR100303681B1 (en)
AT (1)	AT406225B (en)
AU (2)	AU641407B2 (en)
BE (1)	BE1004486A3 (en)
CA (1)	CA2020477C (en)
CH (1)	CH685230A5 (en)
CY (1)	CY1965A (en)
DE (2)	DE4021517B4 (en)
DK (1)	DK175849B1 (en)
FI (3)	FI108611B (en)
FR (1)	FR2649319A1 (en)
GB (2)	GB2234896B (en)
GR (1)	GR1001121B (en)
HK (2)	HK97695A (en)
HU (2)	HU221294B1 (en)
IE (2)	IE64411B1 (en)
IL (3)	IL131881A (en)
IT (1)	IT1241460B (en)
LU (1)	LU87764A1 (en)
MY (1)	MY106722A (en)
NL (1)	NL195027C (en)
NO (2)	NO302928B1 (en)
NZ (1)	NZ234384A (en)
PT (1)	PT94628B (en)
SE (1)	SE512992C2 (en)
SG (1)	SG26416G (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4990336A (en) *	1989-02-08	1991-02-05	Biosearch, Inc.	Sustained release dosage form
YU48420B (en) *	1991-03-25	1998-07-10	Hoechst Aktiengesellschaft	PROCEDURE FOR OBTAINING BIOLOGICAL DEGRADABLE MICROPARTICLES WITH LONG TERM ACTION
CH683149A5 (en) *	1991-07-22	1994-01-31	Debio Rech Pharma Sa	Process for the preparation of microspheres of a biodegradable polymeric material.
US5876452A (en) *	1992-02-14	1999-03-02	Board Of Regents, University Of Texas System	Biodegradable implant
US6013853A (en) *	1992-02-14	2000-01-11	The University Of Texas System	Continuous release polymeric implant carrier
DE4218510A1 (en) *	1992-06-02	1993-12-09	Pharmatech Gmbh	Process for the preparation of biodegradable polyesters
AU4198793A (en) †	1992-07-24	1994-01-27	Takeda Chemical Industries Ltd.	Microparticle preparation and production thereof
CA2123144A1 (en) *	1993-05-10	1994-11-11	David Bodmer	Stabilisation of pharmacologically active compounds in sustained release compositions
GB9310781D0 (en) *	1993-05-25	1993-07-14	Davis Stanley S	Preparation of microparticles
US5603960A (en) *	1993-05-25	1997-02-18	O'hagan; Derek T.	Preparation of microparticles and method of immunization
PL314481A1 (en)	1993-11-19	1996-09-16	Janssen Pharmaceutica Nv	Microencapsulated substituted 3-piperidinyl 1,2-benzoisoxazoles and 1,2-benzoisothiazoles
US6270795B1 (en)	1995-11-09	2001-08-07	Microbiological Research Authority	Method of making microencapsulated DNA for vaccination and gene therapy
ATE192334T1 (en)	1995-11-09	2000-05-15	Microbiological Res Authority	MICRO-ENCAPSULED DNA FOR VACCINATION AND GENE THERAPY
DE19545257A1 (en)	1995-11-24	1997-06-19	Schering Ag	Process for the production of morphologically uniform microcapsules and microcapsules produced by this process
US5817343A (en) *	1996-05-14	1998-10-06	Alkermes, Inc.	Method for fabricating polymer-based controlled-release devices
US5968895A (en) *	1996-12-11	1999-10-19	Praecis Pharmaceuticals, Inc.	Pharmaceutical formulations for sustained drug delivery
US6126919A (en)	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
GB9810236D0 (en)	1998-05-13	1998-07-08	Microbiological Res Authority	Improvements relating to encapsulation of bioactive agents
US6632457B1 (en) *	1998-08-14	2003-10-14	Incept Llc	Composite hydrogel drug delivery systems
US7107268B1 (en)	1998-11-12	2006-09-12	Printable Technologies, Inc.	Centralized system and method for managing enterprise operations
US6226656B1 (en)	1998-11-12	2001-05-01	Sourcefinder, Inc.	System and method for creating, generating and processing user-defined generic specs
US6204308B1 (en)	1999-03-01	2001-03-20	Novartis Ag	Organic compounds
EP1044683A1 (en) *	1999-04-15	2000-10-18	Debio Recherche Pharmaceutique S.A.	One-step dispersion method for the microencapsulation of water soluble substances
US6461631B1 (en) *	1999-11-16	2002-10-08	Atrix Laboratories, Inc.	Biodegradable polymer composition
KR100392501B1 (en) *	2000-06-28	2003-07-22	동국제약 주식회사	Preparation Method for Sustained Release Microparticles by Multiple Emulsion Method and Micropartic les Thereof
US6824822B2 (en) *	2001-08-31	2004-11-30	Alkermes Controlled Therapeutics Inc. Ii	Residual solvent extraction method and microparticles produced thereby
CA2432900C (en)	2000-12-21	2007-09-11	Nektar Therapeutics	Induced phase transition method for the production of microparticles containing hydrophilic active agents
US20040097419A1 (en) *	2002-11-19	2004-05-20	Holger Petersen	Organic compounds
PE20050285A1 (en) *	2003-06-24	2005-06-09	Novartis Ag	PHARMACEUTICAL COMPOSITION INCLUDING CYCLIC ANALOGS OF SOMATOSTATIN
DK1660039T3 (en) *	2003-07-18	2017-01-16	Oakwood Laboratories L L C	PREVENTION OF REDUCTION OF THE POLYMER MOLECULE WEIGHT, THE PREPARATION OF PURPOSES AND GELING IN POLYMER COMPOSITIONS
MY158342A (en)	2003-11-14	2016-09-30	Novartis Ag	Pharmaceutical composition
US20070259047A1 (en) *	2004-02-26	2007-11-08	Yasuaki Ogawa	Protein Sustained-Release Microparticle Preparation for Injection and Process for Producing the Same
DE102004053373A1 (en) *	2004-11-02	2006-05-04	Justus-Liebig-Universität Giessen	Invention relating to nano / meso-fiber anisometric particles in the form of nano / meso-fiber tubes, cables and their curved or branched modifications
KR100741867B1 (en) *	2005-07-05	2007-07-24	전북대학교산학협력단	Method of Preparation of Double Layered Microspheres Using Oil-in-water and Solvent Evaporation
KR101245919B1 (en) *	2005-12-22	2013-03-20	노파르티스 아게	Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
KR100816065B1 (en) *	2006-11-27	2008-03-24	동국제약 주식회사	Method for preparing sustained release microcapsules with excellent initial release control characteristics and microcapsules prepared by the same
RU2541104C2 (en)	2008-01-30	2015-02-10	Новартис Аг	Prolonged release formulation containing octreotide and three linear polymers of poly(lactide-co-glycolic acid)
USRE49251E1 (en)	2010-01-04	2022-10-18	Mapi Pharma Ltd.	Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
RU2013119811A (en) *	2010-09-30	2014-11-10	Эвоник Корпорейшн	METHOD FOR REMOVING RESIDUAL ORGANIC SOLVENT FROM MICROPARTICLES
RU2013119810A (en) *	2010-09-30	2014-11-10	Эвоник Корпорейшн	EMULSION METHOD FOR PRODUCING MICROPARTICLES WITH LOW CONTENT OF RESIDUAL SOLVENT
TW201605488A (en)	2013-10-15	2016-02-16	大塚製藥股份有限公司	Drug for preventing and/or treating polycystic kidney disease
KR102464650B1 (en)	2016-05-03	2022-11-10	엘에스일렉트릭(주)	Current limiting device of circuit breaker
US12097292B2 (en)	2016-08-28	2024-09-24	Mapi Pharma Ltd.	Process for preparing microparticles containing glatiramer acetate
AU2017319728B2 (en)	2016-08-31	2024-09-05	Mapi Pharma Ltd	Depot systems comprising glatiramer acetate
MX2019010174A (en)	2017-03-26	2019-10-15	Mapi Pharma Ltd	Glatiramer depot systems for treating progressive forms of multiple sclerosis.

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3773919A (en) *	1969-10-23	1973-11-20	Du Pont	Polylactide-drug mixtures
CH649217A5 (en) *	1977-08-25	1985-05-15	Sandoz Ag	BROMOCRIPTIN CONTAINING MICROCAPSULES.
US4622244A (en) *	1979-09-04	1986-11-11	The Washington University	Process for preparation of microcapsules
US4293539A (en) *	1979-09-12	1981-10-06	Eli Lilly And Company	Controlled release formulations and method of treatment
DE19375086I2 (en) *	1979-11-27	2003-01-09	Novartis Ag	Polypeptides Process for their preparation pharmaceutical compositions containing these polypeptides and their use
US4389330A (en) *	1980-10-06	1983-06-21	Stolle Research And Development Corporation	Microencapsulation process
US4675189A (en) *	1980-11-18	1987-06-23	Syntex (U.S.A.) Inc.	Microencapsulation of water soluble active polypeptides
PH19942A (en) *	1980-11-18	1986-08-14	Sintex Inc	Microencapsulation of water soluble polypeptides
IE52535B1 (en) *	1981-02-16	1987-12-09	Ici Plc	Continuous release pharmaceutical compositions
DE3378250D1 (en) *	1982-04-22	1988-11-24	Ici Plc	Continuous release formulations
CH656884A5 (en) *	1983-08-26	1986-07-31	Sandoz Ag	POLYOLESTERS, THEIR PRODUCTION AND USE.
US4485101A (en) *	1983-10-11	1984-11-27	Administrators Of The Tulane Educational Fund	Peptides
JPH0657658B2 (en) *	1985-04-11	1994-08-03	住友製薬株式会社	Sustained release formulation
JPS60100516A (en) *	1983-11-04	1985-06-04	Takeda Chem Ind Ltd	Preparation of sustained release microcapsule
GB8331158D0 (en) *	1983-11-22	1983-12-29	British Telecomm	Metal/semiconductor deposition
JPS60181029A (en) *	1984-02-29	1985-09-14	Toyo Jozo Co Ltd	Preparation of sustained release preparation
CH660302A5 (en) *	1984-10-17	1987-04-15	Debiopharm Sa	HETEROGENEOUS PHASE MICRO-ENCAPSULATION PROCESS OF WATER-SOLUBLE DRUG SUBSTANCES.
EP0190833B1 (en) *	1985-02-07	1991-03-27	Takeda Chemical Industries, Ltd.	Method for producing microcapsule
US4725577A (en) *	1985-04-25	1988-02-16	Administrators Of The Tulane Educational Fund	Biologically active lysine containing octapeptides
CH665558A5 (en) *	1985-10-09	1988-05-31	Debiopharm Sa	Phase sepn. prodn. of microcapsules for water soluble pharmaceuticals - using fluoro-substd. aliphatic hydrocarbon as non-solvent in the hardening stage
JP2539789B2 (en) *	1986-03-06	1996-10-02	日本原子力研究所	Process for producing sustained-release drug complex composed of polylactone
GB2193891B (en) *	1986-08-18	1990-07-25	Sandoz Ltd	Nasal pharmaceutical composition containing a somatostatin anologue.
JPH0725689B2 (en) *	1986-10-07	1995-03-22	中外製薬株式会社	Sustained-release preparation containing granulocyte colony-stimulating factor
GB2209937B (en) *	1987-09-21	1991-07-03	Depiopharm S A	Water insoluble polypeptides
CH672887A5 (en) *	1987-10-14	1990-01-15	Debiopharm Sa
DE3738228A1 (en) *	1987-11-11	1989-05-24	Hoechst Ag	METHOD FOR PRODUCING BIODEGRADABLE MICRO-CAPSULES OF WATER-SOLUBLE PEPTIDES AND PROTEINS AND MICRO-CAPSULES OBTAINED BY THIS PROCESS
JP2653255B2 (en) *	1990-02-13	1997-09-17	武田薬品工業株式会社	Long-term sustained release microcapsules

1990
- 1990-06-25 HU HU974/90A patent/HU221294B1/en unknown
- 1990-07-03 GB GB9014704A patent/GB2234896B/en not_active Expired - Lifetime
- 1990-07-03 SG SG1995907374A patent/SG26416G/en unknown
- 1990-07-05 GR GR900100513A patent/GR1001121B/en not_active IP Right Cessation
- 1990-07-05 NZ NZ234384A patent/NZ234384A/en unknown
- 1990-07-05 FR FR9008718A patent/FR2649319A1/en active Granted
- 1990-07-05 DK DK199001625A patent/DK175849B1/en not_active IP Right Cessation
- 1990-07-05 IE IE43894A patent/IE64411B1/en not_active IP Right Cessation
- 1990-07-05 BE BE9000693A patent/BE1004486A3/en not_active IP Right Cessation
- 1990-07-05 CA CA002020477A patent/CA2020477C/en not_active Expired - Lifetime
- 1990-07-05 CH CH2249/90A patent/CH685230A5/en not_active IP Right Cessation
- 1990-07-05 IL IL13188190A patent/IL131881A/en active IP Right Grant
- 1990-07-05 SE SE9002364A patent/SE512992C2/en not_active IP Right Cessation
- 1990-07-05 IL IL9498390A patent/IL94983A/en active IP Right Grant
- 1990-07-05 IE IE243590A patent/IE64216B1/en not_active IP Right Cessation
- 1990-07-05 IT IT48113A patent/IT1241460B/en active IP Right Grant
- 1990-07-05 NL NL9001537A patent/NL195027C/en not_active IP Right Cessation
- 1990-07-05 AU AU58746/90A patent/AU641407B2/en not_active Expired
- 1990-07-05 NO NO903001A patent/NO302928B1/en not_active IP Right Cessation
- 1990-07-05 IL IL13188090A patent/IL131880A/en active IP Right Grant
- 1990-07-06 AT AT0144090A patent/AT406225B/en not_active IP Right Cessation
- 1990-07-06 KR KR1019900010224A patent/KR100303681B1/en not_active Expired - Lifetime
- 1990-07-06 MY MYPI90001133A patent/MY106722A/en unknown
- 1990-07-06 DE DE4021517A patent/DE4021517B4/en not_active Expired - Lifetime
- 1990-07-06 DE DE4042752A patent/DE4042752B4/en not_active Expired - Lifetime
- 1990-07-06 FI FI903429A patent/FI108611B/en active IP Right Grant
- 1990-07-06 JP JP2177665A patent/JPH0832624B2/en not_active Expired - Lifetime
- 1990-07-06 PT PT94628A patent/PT94628B/en not_active IP Right Cessation
- 1990-07-09 LU LU87764A patent/LU87764A1/en unknown
1993
- 1993-03-25 GB GB9306204A patent/GB2265311B/en not_active Expired - Lifetime
1995
- 1995-04-18 JP JP7116539A patent/JPH07309897A/en active Pending
- 1995-04-18 JP JP7116486A patent/JP2931773B2/en not_active Expired - Lifetime
- 1995-06-15 HK HK97695A patent/HK97695A/en not_active IP Right Cessation
- 1995-06-28 HU HU95P/P00523P patent/HU211602A9/en unknown
- 1995-06-29 AU AU23321/95A patent/AU687553B2/en not_active Expired
- 1995-08-15 JP JP7228646A patent/JPH08198771A/en active Pending
1996
- 1996-10-31 HK HK197496A patent/HK197496A/en not_active IP Right Cessation
1997
- 1997-07-04 CY CY196597A patent/CY1965A/en unknown
1998
- 1998-08-26 NO NO19983923A patent/NO320444B1/en unknown
1999
- 1999-09-14 KR KR1019990039209A patent/KR100442931B1/en not_active Expired - Lifetime
2000
- 2000-01-12 FI FI20000060A patent/FI109334B/en active
- 2000-01-12 FI FI20000059A patent/FI109543B/en active
2001
- 2001-01-15 JP JP2001006486A patent/JP2001233897A/en active Pending

Also Published As

Publication number	Publication date
JPH07285853A (en)	1995-10-31
SE512992C2 (en)	2000-06-12
HU903974D0 (en)	1990-11-28
IE64411B1 (en)	1995-08-09
NO983923L (en)	1991-01-08
DK162590D0 (en)	1990-07-05
AU641407B2 (en)	1993-09-23
SG26416G (en)	1995-09-01
JPH0832624B2 (en)	1996-03-29
IT9048113A1 (en)	1992-01-05
JP2001233897A (en)	2001-08-28
FR2649319A1 (en)	1991-01-11
GB2234896B (en)	1994-01-19
IL94983A0 (en)	1991-06-10
NL9001537A (en)	1991-02-01
ATA144090A (en)	1999-08-15
NL195027B (en)	2003-08-01
HK197496A (en)	1996-11-08
NO320444B1 (en)	2005-12-05
BE1004486A3 (en)	1992-12-01
DE4042752B4 (en)	2009-05-07
AU2332195A (en)	1995-09-07
HU221294B1 (en)	2002-09-28
JPH08198771A (en)	1996-08-06
CY1965A (en)	1997-07-04
HUT54037A (en)	1991-01-28
IL94983A (en)	1999-08-17
FI108611B (en)	2002-02-28
NL195027C (en)	2003-12-02
SE9002364D0 (en)	1990-07-05
KR100303681B1 (en)	2002-05-16
HK97695A (en)	1995-06-23
HU211602A9 (en)	1995-12-28
DE4021517B4 (en)	2009-04-09
FI20000059L (en)	2000-01-12
AU687553B2 (en)	1998-02-26
FR2649319B1 (en)	1994-12-09
DE4021517A1 (en)	1991-01-17
FI109334B (en)	2002-07-15
GR900100513A (en)	1991-12-10
JPH07309897A (en)	1995-11-28
GB2234896A (en)	1991-02-20
IL131880A (en)	2001-12-23
IL131881A (en)	2001-12-23
LU87764A1 (en)	1992-03-11
IE64216B1 (en)	1995-07-26
SE9002364L (en)	1991-01-08
GB2265311B (en)	1994-02-09
CH685230A5 (en)	1995-05-15
MY106722A (en)	1995-07-31
KR910002430A (en)	1991-02-25
IT1241460B (en)	1994-01-17
AU5874690A (en)	1991-01-10
DK175849B1 (en)	2005-03-29
IE902435A1 (en)	1991-02-13
PT94628A (en)	1991-03-20
GR1001121B (en)	1993-04-28
JP2931773B2 (en)	1999-08-09
GB9014704D0 (en)	1990-08-22
CA2020477C (en)	2000-11-21
IT9048113A0 (en)	1990-07-05
PT94628B (en)	1997-06-30
GB9306204D0 (en)	1993-05-19
KR100442931B1 (en)	2004-08-02
NO302928B1 (en)	1998-05-11
NZ234384A (en)	1994-05-26
DK162590A (en)	1991-01-08
GB2265311A (en)	1993-09-29
NO983923D0 (en)	1998-08-26
CA2020477A1 (en)	1991-01-08
FI903429A0 (en)	1990-07-06
FI20000060L (en)	2000-01-12
NO903001D0 (en)	1990-07-05
JPH0368511A (en)	1991-03-25
FI109543B (en)	2002-08-30
AT406225B (en)	2000-03-27

Publication	Publication Date	Title
NO903001L (en)	1991-01-08	PROCEDURE FOR MANUFACTURING PHARMACEUTICAL PREPARATIONS WITH EXTENDED RELEASE.
DE69018647D1 (en)	1995-05-18	DRUG.
NO904987D0 (en)	1990-11-16	PROCEDURE FOR THE PREPARATION OF INDOLIDATE DERIVATIVES.
NO902003L (en)	1990-11-09	PROCEDURE FOR THE PREPARATION OF N-HETEROARYL-4-QUINOLINAMINES.
NO901554D0 (en)	1990-04-05	PROCEDURE FOR THE PREPARATION OF DINATE-CEFODIZIM.
NO901070D0 (en)	1990-03-07	PROCEDURE FOR PREPARING TIENO-TRIAZOLO-DIAZEPINE DERIVATIVES.
NO903431D0 (en)	1990-08-03	PROCEDURE FOR THE PREPARATION OF CHROMAND DERIVATIVES.
NO903275L (en)	1991-01-25	PROCEDURE FOR THE PREPARATION OF CHROMAND DERIVATIVES.
NO905377L (en)	1991-06-24	PROCEDURE FOR THE PREPARATION OF GLYCEROLD DERIVATIVES.
NO903043L (en)	1991-01-08	PROCEDURE FOR THE PREPARATION OF CHROMAND DERIVATIVES.
NO905444L (en)	1991-06-21	PROCEDURE FOR THE PREPARATION OF OKSAZOL DERIVATIVES.
NO903207D0 (en)	1990-07-18	PROCEDURE FOR THE PREPARATION OF HALOGENAMINOAROMATIC DERIVATIVES.
NO891574L (en)	1989-10-20	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL USES.
FI913845A0 (en)	1991-08-14	PHARMACEUTICAL FORM PREPARATION FOR BEHANDLING AV TONSILLITIS.
NO902762D0 (en)	1990-06-21	PROCEDURE FOR THE PREPARATION OF 5-PHENYL-2-FURAN DERIVATIVES.
NO900969L (en)	1990-09-04	PROCEDURE FOR THE PREPARATION OF N-ALLYMETATE TRIFLUORMETHYLANILINE.
NO901067D0 (en)	1990-03-07	PROCEDURE FOR THE PREPARATION OF TIOPHENES.
NO901687L (en)	1990-10-19	PROCEDURE FOR THE PREPARATION OF THIAZETOKINOLIN-3-CARBOXYLIC ACID DERIVATIVES.
NO903967D0 (en)	1990-09-11	PROCEDURE FOR THE PREPARATION OF DIHYDROCAFFINE ACID DERIVATIVES.
NO905047L (en)	1991-05-23	PROCEDURE FOR THE PREPARATION OF SELENOFENDER DERIVATIVES.
DE3887237D1 (en)	1994-03-03	Drug.
NO904070L (en)	1991-03-20	PROCEDURE FOR THE PREPARATION OF ALKANPHENONES.
NO904362L (en)	1991-04-10	PROCEDURE FOR THE PREPARATION OF CHROMAND DERIVATIVES.
NO890538D0 (en)	1989-02-08	PROCEDURE FOR THE PREPARATION OF OXADIAZOLYL-AZABICYCLO-HEPTANES.
NO894484D0 (en)	1989-11-10	PROCEDURE FOR THE PREPARATION OF LOW TITANE FERROSILISIUM.

Legal Events

Date	Code	Title	Description
2010-07-19	MK1K	Patent expired